Discover

GDRX
GoodRx Holdings, Inc.
3.06
2 x 2.24
2 x 3.66
bid
ask
+
0.18
6.25%
2 @ 04:00 PM
3.15 +0.09 (2.94%)
Ytd12.92%
1y-38.31%
2.85
day range
3.14
1.77
52 week range
5.81
Open2.88Prev Close2.88Low2.85High3.14Mkt Cap1.04B
Vol2.07MAvg Vol1.53MEPS0.06P/E51.00Forward P/E6.95
Beta1.46Short Ratio1.31Inst. Own55.44%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0550-d Avg2.65200-d Avg2.821yr Est5.12

GDRX News

benzinga.com
GoodRx Launches Its $14.99 Per Month Subscription Service, GoodRx Companion

New service brings together free and low-cost generic medications, affordable online care visits, an

benzinga.com
Citigroup Maintains Buy on GoodRx Holdings, Raises Price Target to $4

Citigroup analyst Daniel Grosslight maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and raises

Why Jim Cramer Says 'Pull The Trigger' On Chevron
benzinga.com
Why Jim Cramer Says 'Pull The Trigger' On Chevron

Cramer recommends buying Chevron (CVX) due to good cash flow and limited downside, and waiting to bu

benzinga.com
TD Cowen Maintains Buy on GoodRx Holdings, Raises Price Target to $4

TD Cowen analyst Charles Rhyee maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and raises the

Earnings Scheduled For May 6, 2026
benzinga.com
Earnings Scheduled For May 6, 2026

benzinga.com
GoodRx Holdings Raises FY2026 Sales Guidance from $750.000M-$780.000M to $765.000M-$785.000M vs $764

GoodRx Holdings (NASDAQ:GDRX) raises FY2026 sales outlook from $750.000 million-$780.000 million to

benzinga.com
GoodRx Holdings Q1 Adj. EPS $0.07, Inline, Sales $194.006M Beat $185.137M Estimate

GoodRx Holdings (NASDAQ:GDRX) reported quarterly earnings of $0.07 per share which met the analyst c

benzinga.com
GoodRx Providing Access To Novo Nordisk's Ozempic Pill At $149/Month

GoodRx (NASDAQ:GDRX), the leading platform for prescription savings in the U.S., today announced tha

GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market
benzinga.com
GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market

GoodRx shares rise as Wegovy HD rollout expands self-pay access, with tiered pricing and mixed techn

benzinga.com
GoodRx Says New Higher Dose Wegovy HD Injection 7.2 Mg Is Now Available To Eligible Self-Pay Patient

Expands access to FDA-approved GLP-1 treatment with transparent pricing and integrated support throu

What's Going On With GoodRx Stock Thursday?
benzinga.com
What's Going On With GoodRx Stock Thursday?

GoodRx shares rise after expanding Eli Lilly's GLP-1 access; analysts keep Buy rating ahead of M

benzinga.com
GoodRx Working With Eli Lilly To Expand Access To FDA-Approved Foundayo At $149/Month

GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced th

benzinga.com
GoodRx Partners With Viatris To Offer Major Brand Medications At A Discount

Collaboration expands access to trusted therapies with discounted cash prices for leading brands inc

benzinga.com
Wells Fargo Maintains Overweight on GoodRx Holdings, Lowers Price Target to $3.5

Wells Fargo analyst Stan Berenshteyn maintains GoodRx Holdings (NASDAQ:GDRX) with a Overweight an

benzinga.com
Citigroup Maintains Buy on GoodRx Holdings, Lowers Price Target to $3.5

Citigroup analyst Daniel Grosslight maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and lowers

benzinga.com
Goldman Sachs Maintains Neutral on GoodRx Holdings, Lowers Price Target to $2.5

Goldman Sachs analyst Eric Sheridan maintains GoodRx Holdings (NASDAQ:GDRX) with a Neutral and lo

benzinga.com
Mizuho Maintains Neutral on GoodRx Holdings, Lowers Price Target to $3

Mizuho analyst Steven Valiquette maintains GoodRx Holdings (NASDAQ:GDRX) with a Neutral and lower

A Glimpse Into The Expert Outlook On GoodRx Holdings Through 4 Analysts
benzinga.com
A Glimpse Into The Expert Outlook On GoodRx Holdings Through 4 Analysts

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

C3.ai Posts Downbeat Results, Joins Trade Desk, FTAI Aviation And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
benzinga.com
C3.ai Posts Downbeat Results, Joins Trade Desk, FTAI Aviation And Other Big Stocks Moving Lower In T

12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket
benzinga.com
Why Marriott Vacations Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket

Earnings Scheduled For February 25, 2026
benzinga.com
Earnings Scheduled For February 25, 2026

benzinga.com
Amazon Beats Google's Capex; Negative Sentiment Is Good; Tradable Low Points For Stocks, Gold, Silve

Sentiment Change Creates Opportunity

benzinga.com
60 Degrees Pharmaceuticals Partners With GoodRx To Expand Access To ARAKODA

GoodRx to offer prescription savings of up to 30% for ARAKODA® (tafenoquine)Collaboration designed t

Demystifying GoodRx Holdings: Insights From 8 Analyst Reviews
benzinga.com
Demystifying GoodRx Holdings: Insights From 8 Analyst Reviews

benzinga.com
Jefferies Downgrades GoodRx Holdings to Hold, Lowers Price Target to $2.75

Jefferies analyst Glen Santangelo downgrades GoodRx Holdings (NASDAQ:GDRX) from Buy to Hold and l

benzinga.com
Citigroup Maintains Buy on GoodRx Holdings, Lowers Price Target to $4.5

Citigroup analyst Daniel Grosslight maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and lowers

Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost
benzinga.com
Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost

Novo Nordisk launches Wegovy weight loss pill in the US, showing up to 17% weight loss, with prices

benzinga.com
Morgan Stanley Maintains Equal-Weight on GoodRx Holdings, Lowers Price Target to $4

Morgan Stanley analyst Craig Hettenbach maintains GoodRx Holdings (NASDAQ:GDRX) with a Equal-Weig

benzinga.com
60 Degrees Pharma To Expand ARAKODA Sales And Marketing, Adding Reps, GoodRx Partnership And Enhance

6-month commercial pilot demonstrated increasing demand among prescribersExpansion plan includes dou

benzinga.com
Barclays Initiates Coverage On GoodRx Holdings with Underweight Rating, Announces Price Target of $3

Barclays analyst Glen Santangelo initiates coverage on GoodRx Holdings (NASDAQ:GDRX) with a Under

Novo Nordisk Leans Into Affordability Amid Rising Competition
benzinga.com
Novo Nordisk Leans Into Affordability Amid Rising Competition

Novo Nordisk offers limited-time $199 pricing on Wegovy and Ozempic, lowers self-pay costs, and prep

benzinga.com
JP Morgan Maintains Overweight on GoodRx Holdings, Lowers Price Target to $5

JP Morgan analyst Lisa Gill maintains GoodRx Holdings (NASDAQ:GDRX) with a Overweight and lowers

benzinga.com
TD Cowen Maintains Buy on GoodRx Holdings, Lowers Price Target to $6

TD Cowen analyst Charles Rhyee maintains GoodRx Holdings (NASDAQ:GDRX) with a Buy and lowers the

benzinga.com
CBS Reporter Jennifer Jacobs Posts On X "News: Other drug websites such as GoodRx won't be partnerin

https://x.com/JenniferJJacobs/status/1986518429478568383

benzinga.com
UBS Maintains Neutral on GoodRx Holdings, Lowers Price Target to $4

UBS analyst Kevin Caliendo maintains GoodRx Holdings (NASDAQ:GDRX) with a Neutral and lowers the

benzinga.com
GoodRx Holdings Q3 Adj. EPS $0.08 Misses $0.09 Estimate, Sales $196.028M Beat $194.550M Estimate

GoodRx Holdings (NASDAQ:GDRX) reported quarterly earnings of $0.08 per share which missed the analys

Earnings Scheduled For November 4, 2025
benzinga.com
Earnings Scheduled For November 4, 2025

Mark Cuban Isn't Convinced TrumpRx Is Going To 'Change The Game' But He's Giving Them 'Credit For Trying'
benzinga.com
Mark Cuban Isn't Convinced TrumpRx Is Going To 'Change The Game' But He's Giving Them 'Credit For Tr

Billionaire entrepreneur Mark Cuban offered rare praise for the Trump administration's push to l

benzinga.com
GoodRx Launches $16/Month Subscription For Hair Loss Treatment With Virtual Care And Home Delivery

The all-in-one solution includes a virtual consultation, clinically proven prescription medication,

benzinga.com
Hy-Vee Announces Through Its Partnership With GoodRx, All Strengths Of GLP-1 Medications Ozempic And

https://www.hy-vee.com/corporate/news-events/news-press-releases/hyvee-pharmacy-patients-can-now-pur

Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch
benzinga.com
Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch

Pharmacies and GoodRx are in talks to join TrumpRx, a new drug pricing site aiming to lower prescrip

benzinga.com
'Retail Pharmacies, GoodRx Say In Talks With Trump Administration On TrumpRx Participation' - Reuter

TrumpRx may expand beyond direct sales by drugmakersPharmacies seek role in TrumpRx for discount vou

benzinga.com
GoodRx And Amgen Partner To Offer Repatha Nationwide For $239

The collaboration with Amgen reduces out-of-pocket costs for patients and expands access to an innov

Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers
benzinga.com
Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers

Hims & Hers investors hit with more bad news as Novo Nordisk partners with GoodRx to offer disco

What's Going On With Hims & Hers Shares Today?
benzinga.com
What's Going On With Hims & Hers Shares Today?

Hims & Hers Health shares are trading lower Tuesday after GoodRx announces a collaboration with

Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk
benzinga.com
Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk

Health Canada approved Ozempic for type 2 diabetes patients with chronic kidney disease after positi

GoodRx (GDRX) Stock Is Sliding Tuesday: What's Going On?
benzinga.com
GoodRx (GDRX) Stock Is Sliding Tuesday: What's Going On?

GoodRx shares are pulling back Tuesday morning. The stock had jumped over 30% Monday after the compa

GoodRx Holdings Surges 5% After Hours on Novo Nordisk Partnership for $499 Monthly Ozempic, Wegovy Access
benzinga.com
GoodRx Holdings Surges 5% After Hours on Novo Nordisk Partnership for $499 Monthly Ozempic, Wegovy A

GoodRx stock rose 5.08% after it partnered with Novo Nordisk to offer Ozempic and Wegovy at a flat $